文献速递肝病消化道肿瘤与早癌

法尼醇X受体缺失使小鼠对乙型肝炎病毒X蛋白诱导的肝癌发生敏感

Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis.
PubMed 文献 · Hepatology · 2017-01-19

该研究探讨法尼醇X受体(FXR)是否影响乙型肝炎病毒X蛋白(HBx)诱导的肝癌发生。研究发现HBx可与FXR相互作用并作为FXR共激活因子,增强FXR应答基因调控;全长HBx而非C端截短型HBx可增强FXR与其应答元件的结合;体内FXR缺失明显使小鼠对HBx诱导的肝癌发生敏感。作者提出全长HBx对FXR的反式激活可能代表抑制肝癌的保护机制。

要点

  • HBx可与FXR相互作用并作为FXR共激活因子增强FXR应答基因调控。
  • 全长HBx而非C端截短型HBx增强FXR与其应答元件的结合。
  • 体内FXR缺失明显使小鼠对HBx诱导的肝癌发生敏感。

核心结论

  • 作者提出全长HBx对FXR的反式激活可能代表抑制肝癌的保护机制,该抑制在出现C端截短型HBx或FXR表达和/或活性降低时可能受损。

研究设计与样本

  • 本研究为实验研究,包含细胞实验与小鼠体内实验,检测HBx与FXR的相互作用及FXR缺失对HBx诱导肝癌发生的影响。

主要发现

  • HBx可与FXR相互作用并作为FXR共激活因子,体内表达HBx增强FXR应答基因调控。
  • 荧光素酶报告基因实验显示HBx增加FXR转录活性。
  • 免疫共沉淀与谷胱甘肽S转移酶pull-down实验证实HBx-FXR相互作用,FXR激活功能1结构域结合于HBx C端第三个α螺旋。
  • 临床肝癌中发现的C端截短型HBx变体不能有效反式激活FXR。
  • 全长HBx而非C端截短型HBx增强FXR与其应答元件的结合。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Chronic hepatitis B virus infection is a major risk factor for hepatocellular carcinoma (HCC). Hepatitis B virus X protein (HBx) is a hepatitis B virus protein that has multiple cellular functions, but its role in HCC pathogenesis has been controversial. Farnesoid X receptor (FXR) is a nuclear receptor with activities in anti-inflammation and inhibition of hepatocarcinogenesis. However, whether or how FXR can impact hepatitis B virus/HBx-induced hepatocarcinogenesis remains unclear. In this study, we showed that HBx can interact with FXR and function as a coactivator of FXR. Expression of HBx in vivo enhanced FXR-responsive gene regulation. HBx also increased the transcriptional activity of FXR in a luciferase reporter gene assay. The HBx-FXR interaction was confirmed by coimmunoprecipitation and glutathione S-transferase pull-down assays, and the FXR activation function 1 domain was mapped to bind to the third α helix in the C terminus of HBx. We also found that the C-terminally truncated variants of HBx, which were found in clinical HCC, were not effective at transactivating FXR. Interestingly, recruitment of the full-length HBx, but not the C-terminally truncated HBx, enhanced the binding of FXR to its response element. In vivo, FXR ablation markedly sensitized mice to HBx-induced hepatocarcinogenesis. CONCLUSIONS: We propose that transactivation of FXR by full-length HBx may represent a protective mechanism to inhibit HCC and that this inhibition may be compromised upon the appearance of C-terminally truncated HBx or when the expression and/or activity of FXR is decreased. (Hepatology 2017;65:893-906).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Niu Y, Xu M, Slagle BL, et al. Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis. Hepatology. 2017. PMID: 28102638. doi:10.1002/hep.28924

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。